Følg
Borja Belandia
Borja Belandia
Staff Scientist, Instituto de Investigaciones Biomédicas "Sols-Morreale" CSIC-UAM
Verifisert e-postadresse på iib.uam.es
Tittel
Sitert av
Sitert av
År
Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes
B Belandia, RL Orford, HC Hurst, MG Parker
The EMBO journal 21 (15), 4094-4103, 2002
3052002
Hey1, a mediator of notch signaling, is an androgen receptor corepressor
B Belandia, SM Powell, JM García-Pedrero, MM Walker, CL Bevan, ...
Molecular and cellular biology 25 (4), 1425-1436, 2005
1522005
Nuclear receptors: a rendezvous for chromatin remodeling factors
B Belandia, MG Parker
Cell 114 (3), 277-280, 2003
1522003
Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors
B Belandia, MG Parker
Journal of Biological Chemistry 275 (40), 30801-30805, 2000
1462000
Thyroid hormone negatively regulates the transcriptional activity of the β-amyloid precursor protein gene
B Belandia, MJ Latasa, A Villa, A Pascual
Journal of Biological Chemistry 273 (46), 30366-30371, 1998
1311998
The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells
JM García-Pedrero, E Kiskinis, MG Parker, B Belandia
Journal of Biological Chemistry 281 (32), 22656-22664, 2006
1162006
Thyroid hormones regulate β-amyloid gene splicing and protein secretion in neuroblastoma cells
MJ Latasa, B Belandia, A Pascual
Endocrinology 139 (6), 2692-2698, 1998
991998
Notch signaling: a potential therapeutic target in prostate cancer
MA Villaronga, CL Bevan, B Belandia
Current cancer drug targets 8 (7), 566-580, 2008
632008
P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
DM Fernández-Aroca, O Roche, S Sabater, R Pascual-Serra, ...
Cancer Letters 451, 23-33, 2019
512019
Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors
DN Lavery, MA Villaronga, MM Walker, A Patel, B Belandia, CL Bevan
Journal of Biological Chemistry 286 (20), 17796-17808, 2011
472011
A response unit in the first exon of the β-amyloid precursor protein gene containing thyroid hormone receptor and Sp1 binding sites mediates negative regulation by 3, 5, 3 …
A Villa, J Santiago, B Belandia, A Pascual
Molecular Endocrinology 18 (4), 863-873, 2004
452004
The transcription factor CREBZF is a novel positive regulator of p53
I López-Mateo, MÁ Villaronga, S Llanos, B Belandia
Cell cycle 11 (20), 3887-3895, 2012
372012
HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions
MA Villaronga, DN Lavery, CL Bevan, S Llanos, B Belandia
Oncogene 29 (3), 411-420, 2010
322010
Identification of BAF57 mutations in human breast cancer cell lines
E Kiskinis, JM García-Pedrero, MA Villaronga, MG Parker, B Belandia
Breast cancer research and treatment 98, 191-198, 2006
312006
Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion
L Serrano-Oviedo, M Ortega-Muelas, J Garcia-Cano, ML Valero, ...
PLoS One 13 (7), e0200878, 2018
282018
Down Regulation of C-MYC and MAX Genes Is Associated to Inhibition of Protein Phosphatase 2A in K562 Human Leukemia Cells
A Lerga, B Belandia, MD Delgado, MA Cuadrado, C Richard, JM Ortiz, ...
Biochemical and biophysical research communications 215 (3), 889-895, 1995
231995
Attenuation of ribosomal protein S6 phosphatase activity in chicken embryo fibroblasts transformed by Rous sarcoma virus
B Belandia, D Brautigan, J Martín-Pérez
Molecular and cellular biology, 1994
231994
Mechanisms of androgen receptor repression in prostate cancer
SM Powell, GN Brooke, HC Whitaker, V Reebye, SC Gamble, D Chotai, ...
Biochemical Society Transactions 34 (6), 1124-1127, 2006
192006
HEY1 functions are regulated by its phosphorylation at Ser-68
I López-Mateo, A Arruabarrena-Aristorena, C Artaza-Irigaray, JA López, ...
Bioscience Reports 36 (3), e00343, 2016
152016
Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient
MÁ Villaronga, I López-Mateo, L Markert, E Espinosa, JÁ Fresno Vara, ...
Breast cancer research and treatment 128, 891-898, 2011
142011
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20